| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of NR3C2 mRNA | CTD | PMID:22975262 |
| 11-deoxycorticosterone | decreases expression | EXP | | 6480464 | Desoxycorticosterone results in decreased expression of NR3C2 mRNA | CTD | PMID:8969928 |
| 11-deoxycortisol | increases activity | ISO | RGD:733363 | 6480464 | Cortodoxone results in increased activity of NR3C2 protein | CTD | PMID:15780662 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:733363 | 6480464 | Metribolone binds to and results in decreased activity of NR3C2 protein; more ... | CTD | PMID:17105867 |
| 17beta-hydroxy-5alpha-androstan-3-one | affects binding | ISO | RGD:733363 | 6480464 | Dihydrotestosterone binds to NR3C2 protein | CTD | PMID:17105867 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:733363 | 6480464 | Dihydrotestosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | CTD | PMID:17105867 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NR3C2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NR3C2 mRNA | CTD | PMID:22298810 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of NR3C2 mRNA | CTD | PMID:21346803 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:733363 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR3C2 mRNA | CTD | PMID:22079614 |
| aflatoxin B1 | affects expression | ISO | RGD:733363 | 6480464 | Aflatoxin B1 affects the expression of NR3C2 protein | CTD | PMID:20106945 |
| aldosterone | multiple interactions | ISO | RGD:733363 | 6480464 | Aldosterone binds to and results in increased activity of NR3C2 protein; more ... | CTD | PMID:17105867 |
| aldosterone | increases expression | ISO | RGD:733363 | 6480464 | Aldosterone results in increased expression of NR3C2 protein; more ... | CTD | PMID:20508287 |
| aldosterone | multiple interactions | EXP | | 6480464 | torsemide inhibits the reaction [Aldosterone binds to NR3C2 protein] | CTD | PMID:7954537 |
| aldosterone | multiple interactions | EXP | | 6480464 | NR3C2 protein promotes the reaction [Aldosterone results in increased expression of GAS6 protein] | CTD | PMID:19564549 |
| aldosterone | increases activity | EXP | | 6480464 | Aldosterone results in increased activity of NR3C2 protein | CTD | PMID:15974890 |
| aldosterone | decreases expression | EXP | | 6480464 | Aldosterone results in decreased expression of NR3C2 mRNA | CTD | PMID:8969928 |
| aldosterone | multiple interactions | EXP | | 6480464 | Aldosterone promotes the reaction [NR3C2 protein binds to CREBBP protein]; more ... | CTD | PMID:19966502 |
| aldosterone | increases activity | ISO | RGD:733363 | 6480464 | Aldosterone results in increased activity of NR3C2 protein | CTD | PMID:15780662 |
| aldosterone | affects localization | ISO | RGD:733363 | 6480464 | Aldosterone affects the localization of NR3C2 protein | CTD | PMID:17596522 |
| amitriptyline | increases expression | EXP | | 6480464 | Amitriptyline results in increased expression of NR3C2 mRNA | CTD | PMID:12393271 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NR3C2 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733363 | 6480464 | Benzo(a)pyrene results in decreased expression of NR3C2 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of NR3C2 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1553569 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of NR3C2 mRNA | CTD | PMID:21715664 |
| bleomycin A2 | decreases expression | EXP | | 6480464 | Bleomycin results in decreased expression of NR3C2 mRNA | CTD | PMID:15808516 |
| caffeine | increases expression | EXP | | 6480464 | Caffeine results in increased expression of NR3C2 mRNA | CTD | PMID:22959462 |
| candesartan | affects expression | EXP | | 6480464 | candesartan affects the expression of NR3C2 mRNA | CTD | PMID:18796534 |
| carbamazepine | increases expression | ISO | RGD:733363 | 6480464 | Carbamazepine results in increased expression of NR3C2 mRNA | CTD | PMID:17112801 |
| choline | multiple interactions | ISO | RGD:1553569 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR3C2 gene | CTD | PMID:20938992 |
| cobalt dichloride | decreases expression | ISO | RGD:733363 | 6480464 | cobaltous chloride results in decreased expression of NR3C2 mRNA | CTD | PMID:19320972 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine deficiency results in increased expression of NR3C2 mRNA | CTD | PMID:22860061 |
| corticosterone | affects binding | ISO | RGD:733363 | 6480464 | Corticosterone binds to NR3C2 protein | CTD | PMID:16061183 |
| cortisol | multiple interactions | ISO | RGD:733363 | 6480464 | [Fludrocortisone binds to and results in increased activity of NR3C2 protein] which results in decreased abundance of Hydrocortisone | CTD | PMID:16566900 |
| cortisol | increases activity | ISO | RGD:733363 | 6480464 | Hydrocortisone results in increased activity of NR3C2 protein | CTD | PMID:15780662 |
| cortisone | increases activity | ISO | RGD:733363 | 6480464 | Cortisone results in increased activity of NR3C2 protein | CTD | PMID:15780662 |
| cyclosporin A | decreases expression | ISO | RGD:733363 | 6480464 | Cyclosporine results in decreased expression of NR3C2 mRNA | CTD | PMID:20106945 |
| dexamethasone | increases expression | ISO | RGD:733363 | 6480464 | Dexamethasone results in increased expression of NR3C2 mRNA | CTD | PMID:19022236 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Fluoxetine affects the reaction [Dexamethasone binds to NR3C2 protein] | CTD | PMID:21281618 |
| dexamethasone | affects binding | EXP | | 6480464 | Dexamethasone binds to NR3C2 protein | CTD | PMID:21281618 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of NR3C2 mRNA | CTD | PMID:18636392 |
| drospirenone | affects binding | EXP | | 6480464 | drospirenone binds to NR3C2 protein | CTD | PMID:1493716 PMID:14667981 |
| drospirenone | affects binding | EXP | | 6480464 | drospirenone binds to NR3C2 protein | CTD | PMID:14667981 PMID:1493716 |
| enalapril | increases expression | EXP | | 6480464 | Enalapril results in increased expression of NR3C2 mRNA | CTD | PMID:18796534 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of NR3C2 mRNA | CTD | PMID:16925589 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of NR3C2 mRNA | CTD | PMID:17920746 |
| fludrocortisone | multiple interactions | ISO | RGD:733363 | 6480464 | [Fludrocortisone binds to and results in increased activity of NR3C2 protein] which results in decreased abundance of Hydrocortisone; more ... | CTD | PMID:16566900 |
| fluoxetine | decreases expression | EXP | | 6480464 | Fluoxetine results in decreased expression of NR3C2 mRNA | CTD | PMID:11406320 |
| fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of NR3C2 protein | CTD | PMID:10929085 |
| fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of NR3C2 mRNA | CTD | PMID:10929085 more ... |
| fluoxetine | multiple interactions | EXP | | 6480464 | Fluoxetine affects the reaction [Dexamethasone binds to NR3C2 protein] | CTD | PMID:21281618 |
| folic acid | multiple interactions | ISO | RGD:1553569 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR3C2 gene | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | RGD:1553569 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR3C2 gene | CTD | PMID:20938992 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of NR3C2 mRNA | CTD | PMID:18636392 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of NR3C2 mRNA | CTD | PMID:18198484 |
| phenylephrine | multiple interactions | EXP | | 6480464 | Phenylephrine results in increased expression of and results in increased localization of NR3C2 protein; more ... | CTD | PMID:19966502 |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of NR3C2 mRNA | CTD | PMID:16533503 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NR3C2 mRNA | CTD | PMID:16533503 |
| progesterone | affects binding | EXP | | 6480464 | Progesterone binds to NR3C2 protein | CTD | PMID:14667981 |
| spironolactone | decreases expression | EXP | | 6480464 | Spironolactone results in decreased expression of NR3C2 mRNA | CTD | PMID:17587755 |
| spironolactone | decreases expression | EXP | | 6480464 | Spironolactone results in decreased expression of NR3C2 protein | CTD | PMID:19114643 |
| spironolactone | increases activity | ISO | RGD:733363 | 6480464 | Spironolactone results in increased activity of NR3C2 protein | CTD | PMID:15780662 |
| spironolactone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Phenylephrine results in increased localization of NR3C2 protein] | CTD | PMID:19966502 |
| testosterone | affects binding | ISO | RGD:733363 | 6480464 | Testosterone binds to NR3C2 protein | CTD | PMID:17105867 |
| testosterone | multiple interactions | ISO | RGD:733363 | 6480464 | Testosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] | CTD | PMID:17105867 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of NR3C2 mRNA | CTD | PMID:16644059 |
| ursodeoxycholic acid | increases localization | EXP | | 6480464 | Ursodeoxycholic Acid results in increased localization of NR3C2 protein | CTD | PMID:15222754 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | NR3C2 mutant form inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]]; more ... | CTD | PMID:15222754 |
| ursodeoxycholic acid | increases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in increased expression of NR3C2 mRNA | CTD | PMID:15222754 |
| venlafaxine | decreases expression | EXP | | 6480464 | venlafaxine results in decreased expression of NR3C2 mRNA | CTD | PMID:11406320 |